Stocks and Investing
Stocks and Investing
Tue, April 28, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, April 27, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jayson Bedford Maintained (TNDM) at Buy with Decreased Target to $81 on, Apr 27th, 2020
Jayson Bedford of Raymond James, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Decreased Target from $91 to $81 on, Apr 27th, 2020.
Jayson has made no other calls on TNDM in the last 4 months.
There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 4 agree with Jayson's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Danielle Antalffy of "SVB Leerink" Downgraded from Buy to Hold on, Friday, April 24th, 2020
- Joanne Wuensch of "Citigroup" Maintained at Hold with Decreased Target to $74 on, Friday, March 27th, 2020
- Rick Wise of "Stifel" Maintained at Hold with Increased Target to $77 on, Tuesday, February 25th, 2020
- Jeff Johnson of "Baird" Downgraded from Buy to Hold and Increased Target to $75 on, Tuesday, February 4th, 2020
This is the rating of the analyst that currently disagrees with Jayson
- Matt OBrien of "Piper Sandler" Maintained at Buy with Increased Target to $90 on, Tuesday, February 25th, 2020